Downregulation of LncRNAH19 and MiR-675 Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells through AKT/GSK-3β/Cdc25A Signaling Pathway

Summary: LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for miR-675. However, it is unknown whether LncRNAH19 and miR-675 are involved in the migration and invasion of hepatocellular carcinoma (HCC) c...

Full description

Saved in:
Bibliographic Details
Published inJournal of Huazhong University of Science and Technology. Medical sciences Vol. 34; no. 3; pp. 363 - 369
Main Author 吕军 马宁 陈锡林 黄晓卉 汪谦
Format Journal Article
LanguageEnglish
Published Heidelberg Huazhong University of Science and Technology 01.06.2014
Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College, Guilin 541001, China%Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China%Department of Surgical Laboratory, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
Subjects
Online AccessGet full text
ISSN1672-0733
1993-1352
DOI10.1007/s11596-014-1284-2

Cover

Loading…
Abstract Summary: LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for miR-675. However, it is unknown whether LncRNAH19 and miR-675 are involved in the migration and invasion of hepatocellular carcinoma (HCC) cells. The purpose of this study was to investigate the effect and mechanism of LncRNAH19 and miR-675 on migration and invasion of HCC cells. The migration and invasion of HCC cells were measured by Transwell migration and invasion assays after transfection of HCC cells with miR-675 inhibitors and LncRNAH19siRNA. The levels of LncRNAH19 and miR-675 were detected by quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR), and the protein expression of AKT, GSK-3[3 and Cdc25A by Western blotting analysis. The expression levels of LncRNAHI9 and miR-675 were higher in MHCC-97H cells than in L02, Huh-7 and HepG2 cells. Transwell migration assay revealed that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the migration of HCC cells (P〈0.01) as compared with the control group. Transwell invasion assay demonstrated that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the invasion of HCC cells (P〈0.01) as compared with the control group. Western blotting analy- sis showed that the expression levels of AKT and Cdc25A were significantly increased (P〈0.05), and the expression level of GSK-313 was significantly decreased (P〈0.05) after treatment with miR-675 inhibitors and LncRNAH19siRNA as compared with the control group. These findings suggested that inhibition of LncRNAH 19 and miR-675 expression can promote migration and invasion of HCC cells via AKT/GSK-3[3/Cdc25A signaling pathway.
AbstractList LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for miR-675. However, it is unknown whether LncRNAH19 and miR-675 are involved in the migration and invasion of hepatocellular carcinoma (HCC) cells. The purpose of this study was to investigate the effect and mechanism of LncRNAH19 and miR-675 on migration and invasion of HCC cells. The migration and invasion of HCC cells were measured by Transwell migration and invasion assays after transfection of HCC cells with miR-675 inhibitors and LncRNAH19siRNA. The levels of LncRNAH19 and miR-675 were detected by quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR), and the protein expression of AKT, GSK-3β and Cdc25A by Western blotting analysis. The expression levels of LncRNAH19 and miR-675 were higher in MHCC-97H cells than in L02, Huh-7 and HepG2 cells. Transwell migration assay revealed that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the migration of HCC cells (P<0.01) as compared with the control group. Transwell invasion assay demonstrated that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the invasion of HCC cells (P<0.01) as compared with the control group. Western blotting analysis showed that the expression levels of AKT and Cdc25A were significantly increased (P<0.05), and the expression level of GSK-3β was significantly decreased (P<0.05) after treatment with miR-675 inhibitors and LncRNAH19siRNA as compared with the control group. These findings suggested that inhibition of LncRNAH19 and miR-675 expression can promote migration and invasion of HCC cells via AKT/GSK-3β/Cdc25A signaling pathway.LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for miR-675. However, it is unknown whether LncRNAH19 and miR-675 are involved in the migration and invasion of hepatocellular carcinoma (HCC) cells. The purpose of this study was to investigate the effect and mechanism of LncRNAH19 and miR-675 on migration and invasion of HCC cells. The migration and invasion of HCC cells were measured by Transwell migration and invasion assays after transfection of HCC cells with miR-675 inhibitors and LncRNAH19siRNA. The levels of LncRNAH19 and miR-675 were detected by quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR), and the protein expression of AKT, GSK-3β and Cdc25A by Western blotting analysis. The expression levels of LncRNAH19 and miR-675 were higher in MHCC-97H cells than in L02, Huh-7 and HepG2 cells. Transwell migration assay revealed that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the migration of HCC cells (P<0.01) as compared with the control group. Transwell invasion assay demonstrated that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the invasion of HCC cells (P<0.01) as compared with the control group. Western blotting analysis showed that the expression levels of AKT and Cdc25A were significantly increased (P<0.05), and the expression level of GSK-3β was significantly decreased (P<0.05) after treatment with miR-675 inhibitors and LncRNAH19siRNA as compared with the control group. These findings suggested that inhibition of LncRNAH19 and miR-675 expression can promote migration and invasion of HCC cells via AKT/GSK-3β/Cdc25A signaling pathway.
LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for miR-675. However, it is unknown whether LncRNAH19 and miR-675 are involved in the migration and invasion of hepatocellular carcinoma (HCC) cells. The purpose of this study was to investigate the effect and mechanism of LncRNAH19 and miR-675 on migration and invasion of HCC cells. The migration and invasion of HCC cells were measured by Transwell migration and invasion assays after transfection of HCC cells with miR-675 inhibitors and LncRNAH19siRNA. The levels of LncRNAH19 and miR-675 were detected by quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR), and the protein expression of AKT, GSK-3β and Cdc25A by Western blotting analysis. The expression levels of LncRNAH19 and miR-675 were higher in MHCC-97H cells than in L02, Huh-7 and HepG2 cells. Transwell migration assay revealed that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the migration of HCC cells (P<0.01) as compared with the control group. Transwell invasion assay demonstrated that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the invasion of HCC cells (P<0.01) as compared with the control group. Western blotting analysis showed that the expression levels of AKT and Cdc25A were significantly increased (P<0.05), and the expression level of GSK-3β was significantly decreased (P<0.05) after treatment with miR-675 inhibitors and LncRNAH19siRNA as compared with the control group. These findings suggested that inhibition of LncRNAH19 and miR-675 expression can promote migration and invasion of HCC cells via AKT/GSK-3β/Cdc25A signaling pathway.
Summary: LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for miR-675. However, it is unknown whether LncRNAH19 and miR-675 are involved in the migration and invasion of hepatocellular carcinoma (HCC) cells. The purpose of this study was to investigate the effect and mechanism of LncRNAH19 and miR-675 on migration and invasion of HCC cells. The migration and invasion of HCC cells were measured by Transwell migration and invasion assays after transfection of HCC cells with miR-675 inhibitors and LncRNAH19siRNA. The levels of LncRNAH19 and miR-675 were detected by quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR), and the protein expression of AKT, GSK-3[3 and Cdc25A by Western blotting analysis. The expression levels of LncRNAHI9 and miR-675 were higher in MHCC-97H cells than in L02, Huh-7 and HepG2 cells. Transwell migration assay revealed that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the migration of HCC cells (P〈0.01) as compared with the control group. Transwell invasion assay demonstrated that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the invasion of HCC cells (P〈0.01) as compared with the control group. Western blotting analy- sis showed that the expression levels of AKT and Cdc25A were significantly increased (P〈0.05), and the expression level of GSK-313 was significantly decreased (P〈0.05) after treatment with miR-675 inhibitors and LncRNAH19siRNA as compared with the control group. These findings suggested that inhibition of LncRNAH 19 and miR-675 expression can promote migration and invasion of HCC cells via AKT/GSK-3[3/Cdc25A signaling pathway.
Summary LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for miR-675. However, it is unknown whether LncRNAH19 and miR-675 are involved in the migration and invasion of hepatocellular carcinoma (HCC) cells. The purpose of this study was to investigate the effect and mechanism of LncRNAH19 and miR-675 on migration and invasion of HCC cells. The migration and invasion of HCC cells were measured by Transwell migration and invasion assays after transfection of HCC cells with miR-675 inhibitors and LncRNAH19siRNA. The levels of LncRNAH19 and miR-675 were detected by quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR), and the protein expression of AKT, GSK-3β and Cdc25A by Western blotting analysis. The expression levels of LncRNAH19 and miR-675 were higher in MHCC-97H cells than in L02, Huh-7 and HepG2 cells. Transwell migration assay revealed that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the migration of HCC cells ( P <0.01) as compared with the control group. Transwell invasion assay demonstrated that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the invasion of HCC cells ( P <0.01) as compared with the control group. Western blotting analysis showed that the expression levels of AKT and Cdc25A were significantly increased ( P <0.05), and the expression level of GSK-3β was significantly decreased ( P <0.05) after treatment with miR-675 inhibitors and LncRNAH19siRNA as compared with the control group. These findings suggested that inhibition of LncRNAH19 and miR-675 expression can promote migration and invasion of HCC cells via AKT/GSK-3β/Cdc25A signaling pathway.
Author 吕军 马宁 陈锡林 黄晓卉 汪谦
AuthorAffiliation Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China Department of Surgical Laboratory, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College, Guilin 541001, China
AuthorAffiliation_xml – name: Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China;Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College, Guilin 541001, China%Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China%Department of Surgical Laboratory, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
Author_xml – sequence: 1
  fullname: 吕军 马宁 陈锡林 黄晓卉 汪谦
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24939300$$D View this record in MEDLINE/PubMed
BookMark eNp9kd1u0zAUxyM0xD7gAbhB5g4JhfojtuPLqsA6rcC0jWvrNHHSlMTu7ISu78JT8CA8Ey4pQ-JiV7bO-f3P1_80ObLOmiR5SfA7grGcBEK4EikmWUponqX0SXJClGIpYZwexb-QNMWSsePkNIQ1xlwKmj1LjmmmmGIYnyQ_3rut9aYeWugbZ5Gr0MIW15-nc6IQ2BJ9aq5TITm68q5zvQkxUPuR3acv7HcIB-F86MCiudlA7wrTtrGmRzPwRWNdB2gWQwH1K--GeoWml7eT85vLlP36OZmVBeVTdNPUFtrG1ugK-tUWds-TpxW0wbw4vGfJ148fbmfzdPHl_GI2XaRFhkWfViCVKEEVZFkSXHKOc5KbTLAKhKCQKSyNKBmvFK5yIJkwucG5lDJjuarKgp0lb8e6W7AV2Fqv3eDjKEH369238v5-qQ2NV8YMExLpNyO98e5uMKHXXRP2-4I1bgiacCa5ogLv0VcHdFh2ptQb33Tgd_rv_SNARqDwLgRvqgeEYL33WI8e69hd7z3WNGrkf5qi6f840nto2keVdFSG2MXWxv9b9DHR60O7lbP1XdQ9zJgpxUXOOPsNxnbEwg
CitedBy_id crossref_primary_10_3390_ncrna6030034
crossref_primary_10_12998_wjcc_v9_i32_9699
crossref_primary_10_1016_j_mrrev_2021_108375
crossref_primary_10_1139_bcb_2019_0362
crossref_primary_10_1016_j_ijdevneu_2018_03_009
crossref_primary_10_1016_j_chemosphere_2018_05_048
crossref_primary_10_1007_s12010_022_04191_1
crossref_primary_10_1002_jcb_26883
crossref_primary_10_1155_2017_6049480
crossref_primary_10_3934_molsci_2016_2_104
crossref_primary_10_1093_bfgp_elw011
crossref_primary_10_1007_s12072_024_10722_1
crossref_primary_10_1155_2015_473942
crossref_primary_10_1155_2019_6587429
crossref_primary_10_1177_10732748241284821
crossref_primary_10_1155_2018_8126208
crossref_primary_10_3389_fmed_2024_1456963
crossref_primary_10_3389_fcell_2021_796740
crossref_primary_10_1016_j_phrs_2020_105195
crossref_primary_10_3390_ncrna9020019
crossref_primary_10_3748_wjg_v24_i5_549
crossref_primary_10_1080_21655979_2021_1995573
crossref_primary_10_1016_j_mrrev_2015_08_002
crossref_primary_10_4236_jct_2018_93026
crossref_primary_10_1042_BSR20160532
crossref_primary_10_1007_s11596_015_1452_z
crossref_primary_10_1002_jcb_29649
crossref_primary_10_1007_s13402_018_0412_6
crossref_primary_10_3727_096504015X14496932933575
crossref_primary_10_3727_096504016X14549667334007
crossref_primary_10_1016_j_gene_2017_12_051
crossref_primary_10_1007_s11596_024_2899_6
crossref_primary_10_1016_j_genrep_2022_101724
crossref_primary_10_1159_000495151
crossref_primary_10_1007_s13577_023_00958_8
crossref_primary_10_3390_ijms19030682
crossref_primary_10_1155_2018_1808370
crossref_primary_10_1155_2020_1634252
crossref_primary_10_1177_1179299X17737301
crossref_primary_10_1007_s13277_016_4852_1
crossref_primary_10_1016_j_lfs_2020_118560
crossref_primary_10_18632_aging_205523
crossref_primary_10_1155_2018_1690747
crossref_primary_10_1186_s12885_018_4831_6
crossref_primary_10_1002_jcp_27269
crossref_primary_10_3748_wjg_v23_i32_5860
crossref_primary_10_1186_s12943_015_0452_8
crossref_primary_10_2217_epi_2021_0165
crossref_primary_10_4254_wjh_v7_i28_2781
crossref_primary_10_1186_s12943_016_0545_z
crossref_primary_10_3892_mmr_2017_8264
crossref_primary_10_1007_s12038_020_00118_2
crossref_primary_10_1586_17474124_2016_1116382
crossref_primary_10_1080_15476286_2024_2440678
crossref_primary_10_3892_or_2016_4929
crossref_primary_10_1016_j_semcancer_2017_12_010
crossref_primary_10_1038_srep20559
crossref_primary_10_3892_mmr_2018_8746
crossref_primary_10_1002_jcb_26835
crossref_primary_10_1007_s11033_020_05695_x
Cites_doi 10.1016/j.ccr.2007.12.002
10.1371/journal.pone.0000845
10.1002/ijc.25516
10.1002/mc.10075
10.1038/nature02369
10.1261/rna.351707
10.1038/nrc1840
10.1111/febs.12185
10.1038/365764a0
10.1074/jbc.M112.342113
10.1371/journal.pgen.1003368
10.1093/carcin/bgp181
10.1038/35096075
10.1007/s12032-011-0004-z
10.1016/S0960-9822(02)00843-6
10.1093/embo-reports/kvd018
10.1016/j.gene.2012.01.012
10.1177/147323001103900608
10.1016/j.ygeno.2008.01.007
10.1158/1078-0432.CCR-09-1840
10.1371/journal.pone.0044206
10.1038/sj.bjc.6606010
10.1093/hmg/ddq353
10.1038/351153a0
10.1073/pnas.98.2.591
10.1016/j.canlet.2013.01.033
10.1016/j.ccr.2005.01.009
10.1016/j.chembiol.2004.07.007
10.1093/carcin/bgs381
10.1038/378785a0
10.1128/MCB.19.9.6183
10.1002/hep.23443
ContentType Journal Article
Copyright Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2014
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2014
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/s11596-014-1284-2
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Downregulation of LncRNAH19 and MiR-675 Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells through AKT/GSK-3β/Cdc25A Signaling Pathway
EISSN 1993-1352
EndPage 369
ExternalDocumentID tjykdxxb_e201403011
24939300
10_1007_s11596_014_1284_2
49956835
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: grants from the National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province,China; Science and Technology Planning Project of Guangdong Province,China; the Foundation of the Health Department of Guangxi Province,China; the Foundation of Scientific Research and Technology Development Project of Guilin,China; the Foundation of Scientific Research and Technology Development Project of Guangxi Province,China; Foundation for Youth Teacher by Sun Yat-Sen University
  funderid: (.81071871,81101862 and 81172079); (.S2013010016831,and 10451008901006014); (2009B030801014,2010B060500007 and 2011B060300012); (Z2007212); (key scientific and technological projects and trial production of new products,20110321); (GuiKeGong1355005-3-5); (11ykpy16)
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJNI
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
DPUIP
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
ABQSL
H13
AAYXX
ADHKG
AGQPQ
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
4A8
93N
PSX
ID FETCH-LOGICAL-c406t-fa796da9c1bd10d550818e463fa662a4907e6d35f90f8a146e8e087774389fdc3
IEDL.DBID U2A
ISSN 1672-0733
IngestDate Thu May 29 04:06:47 EDT 2025
Fri Jul 11 05:39:39 EDT 2025
Thu Jan 02 23:11:23 EST 2025
Wed Aug 20 07:41:09 EDT 2025
Thu Apr 24 23:02:40 EDT 2025
Fri Feb 21 02:37:18 EST 2025
Wed Feb 14 10:36:43 EST 2024
IsPeerReviewed false
IsScholarly false
Issue 3
Keywords migration
miR-675
invasion
LncRNAH19
hepatocellular carcinoma
AKT/GSK-3β/Cdc25A signaling pathway
AKT/G SK-3β/Cdc25A signaling pathway
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c406t-fa796da9c1bd10d550818e463fa662a4907e6d35f90f8a146e8e087774389fdc3
Notes LncRNAH19; miR-675; hepatocellular carcinoma; migration; invasion; AKT/GSK-313/Cdc25A signaling pathway
42-1679/R
Summary: LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for miR-675. However, it is unknown whether LncRNAH19 and miR-675 are involved in the migration and invasion of hepatocellular carcinoma (HCC) cells. The purpose of this study was to investigate the effect and mechanism of LncRNAH19 and miR-675 on migration and invasion of HCC cells. The migration and invasion of HCC cells were measured by Transwell migration and invasion assays after transfection of HCC cells with miR-675 inhibitors and LncRNAH19siRNA. The levels of LncRNAH19 and miR-675 were detected by quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR), and the protein expression of AKT, GSK-3[3 and Cdc25A by Western blotting analysis. The expression levels of LncRNAHI9 and miR-675 were higher in MHCC-97H cells than in L02, Huh-7 and HepG2 cells. Transwell migration assay revealed that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the migration of HCC cells (P〈0.01) as compared with the control group. Transwell invasion assay demonstrated that the miR-675 inhibitor and LncRNAH19siRNA could significantly increase the invasion of HCC cells (P〈0.01) as compared with the control group. Western blotting analy- sis showed that the expression levels of AKT and Cdc25A were significantly increased (P〈0.05), and the expression level of GSK-313 was significantly decreased (P〈0.05) after treatment with miR-675 inhibitors and LncRNAH19siRNA as compared with the control group. These findings suggested that inhibition of LncRNAH 19 and miR-675 expression can promote migration and invasion of HCC cells via AKT/GSK-3[3/Cdc25A signaling pathway.
Jun LV , Ling MA ,Xi-lin CHEN , Xiao-hui HUANG , Qian WANG ( 1Department of Hepatobiliary Surgery, 2Department of Surgical Laboratory, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China 3Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College, Guilin 541001, China)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24939300
PQID 1537592601
PQPubID 23479
PageCount 7
ParticipantIDs wanfang_journals_tjykdxxb_e201403011
proquest_miscellaneous_1537592601
pubmed_primary_24939300
crossref_primary_10_1007_s11596_014_1284_2
crossref_citationtrail_10_1007_s11596_014_1284_2
springer_journals_10_1007_s11596_014_1284_2
chongqing_primary_49956835
PublicationCentury 2000
PublicationDate 2014-06-01
PublicationDateYYYYMMDD 2014-06-01
PublicationDate_xml – month: 06
  year: 2014
  text: 2014-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Heidelberg
PublicationPlace_xml – name: Heidelberg
– name: China
PublicationSubtitle Medical Sciences
PublicationTitle Journal of Huazhong University of Science and Technology. Medical sciences
PublicationTitleAbbrev J. Huazhong Univ. Sci. Technol. [Med. Sci.]
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Edition
PublicationTitle_FL Journal of Huazhong University of Science and Technology(Medical Science)
PublicationYear 2014
Publisher Huazhong University of Science and Technology
Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College, Guilin 541001, China%Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China%Department of Surgical Laboratory, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
Publisher_xml – name: Huazhong University of Science and Technology
– name: Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
– name: Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College, Guilin 541001, China%Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China%Department of Surgical Laboratory, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
References Du, Kong, You (CR19) 2012; 287
Cross, Alessi, Cohen (CR16) 1995; 378
Cai, Cullen (CR14) 2007; 13
Yao, Liang, Huang (CR5) 2010; 51
Xia, Ooi, Hui (CR6) 2012; 7
Blomberg, Hoffmann (CR28) 1999; 19
Lai, Yang, Zhou (CR8) 2012; 29
Tripathi, Shen, Chakraborty (CR27) 2013; 9
Kang, Wei, Honaker (CR17) 2008; 13
Ayesh, Matouk, Schneider (CR22) 2002; 35
Wendel, De Stanchina, Fridman (CR15) 2004; 428
Nakagawa, Chadwick, Peltomaki (CR13) 2001; 98
Kristjánsdóttir, Rudolph (CR18) 2004; 11
Matouk, DeGroot, Mezan (CR10) 2007; 2
Chen, Lp, Cheng (CR12) 2000; 6
Luo, Li, Wang (CR24) 2013; 280
Luo, Li, Wang (CR23) 2013; 333
Wong, Ching, Chan (CR4) 2010; 16
Zhang, Yang, Yuan (CR26) 2013; 34
Esquela-Kerscher, Slack (CR2) 2006; 6
Molinari, Mercurio, Dominguez (CR29) 2000; 1
Huarte, Rinn (CR7) 2010; 19R2
Geng, Xie, Li (CR9) 2011; 39
Hao, Crenshaw, Moulton (CR25) 1993; 365
Huang, He (CR3) 2011; 104
Cohen, Frame (CR31) 2001; 2
Bartolomei, Zemel, Tilghman (CR21) 1991; 351
Yang, Li, Wang (CR30) 2012; 496
Shtivelman, Sussman, Stokoe (CR33) 2002; 12
Wu, Qin, Li (CR11) 2008; 91
Puc, Keniry, Li (CR32) 2005; 7
Ferlay, Shin, Bray (CR1) 2010; 127
Tsang, Ng, Ng (CR20) 2010; 31
MC Lai (1284_CR8) 2012; 29
V Tripathi (1284_CR27) 2013; 9
YJ Geng (1284_CR9) 2011; 39
P Cohen (1284_CR31) 2001; 2
X Cai (1284_CR14) 2007; 13
T Kang (1284_CR17) 2008; 13
I Blomberg (1284_CR28) 1999; 19
K Kristjánsdóttir (1284_CR18) 2004; 11
MS Bartolomei (1284_CR21) 1991; 351
IJ Matouk (1284_CR10) 2007; 2
Y Du (1284_CR19) 2012; 287
C Yang (1284_CR30) 2012; 496
Y Hao (1284_CR25) 1993; 365
QW Wong (1284_CR4) 2010; 16
A Esquela-Kerscher (1284_CR2) 2006; 6
M Luo (1284_CR24) 2013; 280
S Huang (1284_CR3) 2011; 104
J Puc (1284_CR32) 2005; 7
HG Wendel (1284_CR15) 2004; 428
M Luo (1284_CR23) 2013; 333
CL Chen (1284_CR12) 2000; 6
L Zhang (1284_CR26) 2013; 34
H Xia (1284_CR6) 2012; 7
S Ayesh (1284_CR22) 2002; 35
E Shtivelman (1284_CR33) 2002; 12
J Yao (1284_CR5) 2010; 51
DA Cross (1284_CR16) 1995; 378
H Nakagawa (1284_CR13) 2001; 98
J Ferlay (1284_CR1) 2010; 127
J Wu (1284_CR11) 2008; 91
M Molinari (1284_CR29) 2000; 1
WP Tsang (1284_CR20) 2010; 31
M Huarte (1284_CR7) 2010; 19R2
23222811 - Carcinogenesis. 2013 Mar;34(3):577-86
23399020 - FEBS J. 2013 Apr;280(7):1709-16
15710331 - Cancer Cell. 2005 Feb;7(2):193-204
17237358 - RNA. 2007 Mar;13(3):313-6
19926638 - Carcinogenesis. 2010 Mar;31(3):350-8
22685290 - J Biol Chem. 2012 Jul 27;287(31):26302-11
11120891 - Proc Natl Acad Sci U S A. 2001 Jan 16;98 (2):591-6
1709450 - Nature. 1991 May 9;351(6322):153-5
7692308 - Nature. 1993 Oct 21;365(6448):764-7
22285928 - Gene. 2012 Mar 15;496(1):8-16
20054866 - Hepatology. 2010 Mar;51(3):846-56
8524413 - Nature. 1995 Dec 21-28;378(6559):785-9
20103675 - Clin Cancer Res. 2010 Feb 1;16(3):867-75
17786216 - PLoS One. 2007 Sep 05;2(9):e845
12062056 - Curr Biol. 2002 Jun 4;12 (11):919-24
12325036 - Mol Carcinog. 2002 Oct;35(2):63-74
23555285 - PLoS Genet. 2013 Mar;9(3):e1003368
10454565 - Mol Cell Biol. 1999 Sep;19(9):6183-94
15324805 - Chem Biol. 2004 Aug;11(8):1043-51
18358696 - Genomics. 2008 May;91(5):443-50
18167338 - Cancer Cell. 2008 Jan;13(1):36-47
23354591 - Cancer Lett. 2013 Jun 10;333(2):213-21
21351269 - Int J Cancer. 2010 Dec 15;127(12):2893-917
20729297 - Hum Mol Genet. 2010 Oct 15;19(R2):R152-61
16557279 - Nat Rev Cancer. 2006 Apr;6(4):259-69
22962603 - PLoS One. 2012;7(9):e44206
11256629 - EMBO Rep. 2000 Jul;1(1):71-9
15029198 - Nature. 2004 Mar 18;428(6980):332-7
11584304 - Nat Rev Mol Cell Biol. 2001 Oct;2(10):769-76
10690526 - Clin Cancer Res. 2000 Feb;6(2):474-9
21102580 - Br J Cancer. 2011 Jan 18;104(2):235-40
22289527 - J Int Med Res. 2011;39(6):2119-28
21678027 - Med Oncol. 2012 Sep;29(3):1810-6
References_xml – volume: 13
  start-page: 36
  issue: 1
  year: 2008
  end-page: 47
  ident: CR17
  article-title: GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.12.002
– volume: 2
  start-page: e845
  issue: 9
  year: 2007
  ident: CR10
  article-title: The H19 non-coding RNA is essential for human tumor growth
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0000845
– volume: 127
  start-page: 2893
  issue: 12
  year: 2010
  end-page: 2917
  ident: CR1
  article-title: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
  publication-title: Int J Cancer
  doi: 10.1002/ijc.25516
– volume: 35
  start-page: 63
  issue: 2
  year: 2002
  end-page: 74
  ident: CR22
  article-title: Possible physiological role of H19 RNA
  publication-title: Mol Carcinog
  doi: 10.1002/mc.10075
– volume: 428
  start-page: 332
  issue: 6980
  year: 2004
  end-page: 337
  ident: CR15
  article-title: Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy
  publication-title: Nature
  doi: 10.1038/nature02369
– volume: 13
  start-page: 313
  issue: 3
  year: 2007
  end-page: 316
  ident: CR14
  article-title: The imprinted H19 noncoding RNA is a primary micro-RNA precursor
  publication-title: RNA
  doi: 10.1261/rna.351707
– volume: 6
  start-page: 259
  issue: 4
  year: 2006
  end-page: 269
  ident: CR2
  article-title: Oncomirs-microRNAs with a role in cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1840
– volume: 19
  start-page: 6183
  issue: 9
  year: 1999
  end-page: 6194
  ident: CR28
  article-title: Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases
  publication-title: Mol Cell Biol
– volume: 280
  start-page: 1709
  issue: 7
  year: 2013
  end-page: 1716
  ident: CR24
  article-title: Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression
  publication-title: FEBS J
  doi: 10.1111/febs.12185
– volume: 365
  start-page: 764
  issue: 6448
  year: 1993
  end-page: 767
  ident: CR25
  article-title: Tumour-suppressor activity of H19 RNA
  publication-title: Nature
  doi: 10.1038/365764a0
– volume: 287
  start-page: 26302
  issue: 31
  year: 2012
  end-page: 26311
  ident: CR19
  article-title: Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus x protein promotes hepatoma cell proliferation via down-regulating p18
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.342113
– volume: 9
  start-page: e1003368
  issue: 3
  year: 2013
  ident: CR27
  article-title: Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1003368
– volume: 31
  start-page: 350
  issue: 3
  year: 2010
  end-page: 358
  ident: CR20
  article-title: Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgp181
– volume: 2
  start-page: 769
  issue: 10
  year: 2001
  end-page: 776
  ident: CR31
  article-title: The renaissance of GSK3
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/35096075
– volume: 29
  start-page: 1810
  issue: 3
  year: 2012
  end-page: 1816
  ident: CR8
  article-title: Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation
  publication-title: Med Oncol
  doi: 10.1007/s12032-011-0004-z
– volume: 12
  start-page: 919
  issue: 11
  year: 2002
  end-page: 924
  ident: CR33
  article-title: A role for PI3-kinase and PKB activity in the G2/M phase of the cell cycle
  publication-title: Curr Biol
  doi: 10.1016/S0960-9822(02)00843-6
– volume: 1
  start-page: 71
  issue: 1
  year: 2000
  end-page: 79
  ident: CR29
  article-title: Human Cdc25A inactivation in response to S phase inhibition and its role in preventing premature mitosis
  publication-title: EMBO Rep
  doi: 10.1093/embo-reports/kvd018
– volume: 6
  start-page: 474
  issue: 2
  year: 2000
  end-page: 479
  ident: CR12
  article-title: Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer
  publication-title: Clin Cancer Res
– volume: 496
  start-page: 8
  issue: 1
  year: 2012
  end-page: 16
  ident: CR30
  article-title: Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells
  publication-title: Gene
  doi: 10.1016/j.gene.2012.01.012
– volume: 39
  start-page: 2119
  issue: 6
  year: 2011
  end-page: 2128
  ident: CR9
  article-title: Large intervening non-coding RNAHOTAIR is associated with hepatocellular carcinoma progression
  publication-title: J Int Med Res
  doi: 10.1177/147323001103900608
– volume: 91
  start-page: 443
  issue: 5
  year: 2008
  end-page: 450
  ident: CR11
  article-title: Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma
  publication-title: Genomics
  doi: 10.1016/j.ygeno.2008.01.007
– volume: 16
  start-page: 867
  issue: 3
  year: 2010
  end-page: 875
  ident: CR4
  article-title: MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-09-1840
– volume: 7
  start-page: e44206
  issue: 9
  year: 2012
  ident: CR6
  article-title: MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0044206
– volume: 104
  start-page: 235
  issue: 2
  year: 2011
  end-page: 240
  ident: CR3
  article-title: The role of microRNAs in liver cancer progression
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6606010
– volume: 51
  start-page: 846
  issue: 3
  year: 2010
  end-page: 856
  ident: CR5
  article-title: MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma
  publication-title: Hepatology
– volume: 19R2
  start-page: 152
  year: 2010
  end-page: 161
  ident: CR7
  article-title: Large non-coding RNAs: missing links in cancer?
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddq353
– volume: 351
  start-page: 153
  issue: 6322
  year: 1991
  end-page: 155
  ident: CR21
  article-title: Parental imprinting of the mouse H19 gene
  publication-title: Nature
  doi: 10.1038/351153a0
– volume: 98
  start-page: 591
  issue: 2
  year: 2001
  end-page: 596
  ident: CR13
  article-title: Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.98.2.591
– volume: 333
  start-page: 213
  issue: 2
  year: 2013
  end-page: 221
  ident: CR23
  article-title: Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.01.033
– volume: 7
  start-page: 193
  issue: 2
  year: 2005
  end-page: 204
  ident: CR32
  article-title: Lack of PTEN sequesters CHK1 and initiates genetic instability
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2005.01.009
– volume: 11
  start-page: 1043
  issue: 8
  year: 2004
  end-page: 1051
  ident: CR18
  article-title: Cdc25 phosphatases and cancer
  publication-title: Chem Biol
  doi: 10.1016/j.chembiol.2004.07.007
– volume: 34
  start-page: 577
  issue: 3
  year: 2013
  end-page: 586
  ident: CR26
  article-title: Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgs381
– volume: 378
  start-page: 785
  issue: 6559
  year: 1995
  end-page: 789
  ident: CR16
  article-title: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
  publication-title: Nature
  doi: 10.1038/378785a0
– volume: 11
  start-page: 1043
  issue: 8
  year: 2004
  ident: 1284_CR18
  publication-title: Chem Biol
  doi: 10.1016/j.chembiol.2004.07.007
– volume: 7
  start-page: e44206
  issue: 9
  year: 2012
  ident: 1284_CR6
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0044206
– volume: 31
  start-page: 350
  issue: 3
  year: 2010
  ident: 1284_CR20
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgp181
– volume: 12
  start-page: 919
  issue: 11
  year: 2002
  ident: 1284_CR33
  publication-title: Curr Biol
  doi: 10.1016/S0960-9822(02)00843-6
– volume: 13
  start-page: 313
  issue: 3
  year: 2007
  ident: 1284_CR14
  publication-title: RNA
  doi: 10.1261/rna.351707
– volume: 280
  start-page: 1709
  issue: 7
  year: 2013
  ident: 1284_CR24
  publication-title: FEBS J
  doi: 10.1111/febs.12185
– volume: 2
  start-page: 769
  issue: 10
  year: 2001
  ident: 1284_CR31
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/35096075
– volume: 351
  start-page: 153
  issue: 6322
  year: 1991
  ident: 1284_CR21
  publication-title: Nature
  doi: 10.1038/351153a0
– volume: 19
  start-page: 6183
  issue: 9
  year: 1999
  ident: 1284_CR28
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.19.9.6183
– volume: 29
  start-page: 1810
  issue: 3
  year: 2012
  ident: 1284_CR8
  publication-title: Med Oncol
  doi: 10.1007/s12032-011-0004-z
– volume: 378
  start-page: 785
  issue: 6559
  year: 1995
  ident: 1284_CR16
  publication-title: Nature
  doi: 10.1038/378785a0
– volume: 6
  start-page: 259
  issue: 4
  year: 2006
  ident: 1284_CR2
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1840
– volume: 91
  start-page: 443
  issue: 5
  year: 2008
  ident: 1284_CR11
  publication-title: Genomics
  doi: 10.1016/j.ygeno.2008.01.007
– volume: 365
  start-page: 764
  issue: 6448
  year: 1993
  ident: 1284_CR25
  publication-title: Nature
  doi: 10.1038/365764a0
– volume: 333
  start-page: 213
  issue: 2
  year: 2013
  ident: 1284_CR23
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.01.033
– volume: 51
  start-page: 846
  issue: 3
  year: 2010
  ident: 1284_CR5
  publication-title: Hepatology
  doi: 10.1002/hep.23443
– volume: 496
  start-page: 8
  issue: 1
  year: 2012
  ident: 1284_CR30
  publication-title: Gene
  doi: 10.1016/j.gene.2012.01.012
– volume: 16
  start-page: 867
  issue: 3
  year: 2010
  ident: 1284_CR4
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-09-1840
– volume: 127
  start-page: 2893
  issue: 12
  year: 2010
  ident: 1284_CR1
  publication-title: Int J Cancer
  doi: 10.1002/ijc.25516
– volume: 39
  start-page: 2119
  issue: 6
  year: 2011
  ident: 1284_CR9
  publication-title: J Int Med Res
  doi: 10.1177/147323001103900608
– volume: 104
  start-page: 235
  issue: 2
  year: 2011
  ident: 1284_CR3
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6606010
– volume: 98
  start-page: 591
  issue: 2
  year: 2001
  ident: 1284_CR13
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.98.2.591
– volume: 1
  start-page: 71
  issue: 1
  year: 2000
  ident: 1284_CR29
  publication-title: EMBO Rep
  doi: 10.1093/embo-reports/kvd018
– volume: 6
  start-page: 474
  issue: 2
  year: 2000
  ident: 1284_CR12
  publication-title: Clin Cancer Res
– volume: 35
  start-page: 63
  issue: 2
  year: 2002
  ident: 1284_CR22
  publication-title: Mol Carcinog
  doi: 10.1002/mc.10075
– volume: 9
  start-page: e1003368
  issue: 3
  year: 2013
  ident: 1284_CR27
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1003368
– volume: 34
  start-page: 577
  issue: 3
  year: 2013
  ident: 1284_CR26
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgs381
– volume: 287
  start-page: 26302
  issue: 31
  year: 2012
  ident: 1284_CR19
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.342113
– volume: 13
  start-page: 36
  issue: 1
  year: 2008
  ident: 1284_CR17
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.12.002
– volume: 7
  start-page: 193
  issue: 2
  year: 2005
  ident: 1284_CR32
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2005.01.009
– volume: 19R2
  start-page: 152
  year: 2010
  ident: 1284_CR7
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddq353
– volume: 2
  start-page: e845
  issue: 9
  year: 2007
  ident: 1284_CR10
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0000845
– volume: 428
  start-page: 332
  issue: 6980
  year: 2004
  ident: 1284_CR15
  publication-title: Nature
  doi: 10.1038/nature02369
– reference: 8524413 - Nature. 1995 Dec 21-28;378(6559):785-9
– reference: 23354591 - Cancer Lett. 2013 Jun 10;333(2):213-21
– reference: 11120891 - Proc Natl Acad Sci U S A. 2001 Jan 16;98 (2):591-6
– reference: 17786216 - PLoS One. 2007 Sep 05;2(9):e845
– reference: 18167338 - Cancer Cell. 2008 Jan;13(1):36-47
– reference: 22285928 - Gene. 2012 Mar 15;496(1):8-16
– reference: 16557279 - Nat Rev Cancer. 2006 Apr;6(4):259-69
– reference: 22289527 - J Int Med Res. 2011;39(6):2119-28
– reference: 1709450 - Nature. 1991 May 9;351(6322):153-5
– reference: 7692308 - Nature. 1993 Oct 21;365(6448):764-7
– reference: 15710331 - Cancer Cell. 2005 Feb;7(2):193-204
– reference: 15029198 - Nature. 2004 Mar 18;428(6980):332-7
– reference: 23399020 - FEBS J. 2013 Apr;280(7):1709-16
– reference: 11584304 - Nat Rev Mol Cell Biol. 2001 Oct;2(10):769-76
– reference: 10690526 - Clin Cancer Res. 2000 Feb;6(2):474-9
– reference: 20729297 - Hum Mol Genet. 2010 Oct 15;19(R2):R152-61
– reference: 18358696 - Genomics. 2008 May;91(5):443-50
– reference: 20054866 - Hepatology. 2010 Mar;51(3):846-56
– reference: 15324805 - Chem Biol. 2004 Aug;11(8):1043-51
– reference: 12062056 - Curr Biol. 2002 Jun 4;12 (11):919-24
– reference: 21678027 - Med Oncol. 2012 Sep;29(3):1810-6
– reference: 10454565 - Mol Cell Biol. 1999 Sep;19(9):6183-94
– reference: 19926638 - Carcinogenesis. 2010 Mar;31(3):350-8
– reference: 22962603 - PLoS One. 2012;7(9):e44206
– reference: 21351269 - Int J Cancer. 2010 Dec 15;127(12):2893-917
– reference: 20103675 - Clin Cancer Res. 2010 Feb 1;16(3):867-75
– reference: 12325036 - Mol Carcinog. 2002 Oct;35(2):63-74
– reference: 23222811 - Carcinogenesis. 2013 Mar;34(3):577-86
– reference: 21102580 - Br J Cancer. 2011 Jan 18;104(2):235-40
– reference: 22685290 - J Biol Chem. 2012 Jul 27;287(31):26302-11
– reference: 11256629 - EMBO Rep. 2000 Jul;1(1):71-9
– reference: 23555285 - PLoS Genet. 2013 Mar;9(3):e1003368
– reference: 17237358 - RNA. 2007 Mar;13(3):313-6
SSID ssj0057624
Score 1.8628613
Snippet Summary: LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for...
Summary LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for...
LncRNAH19 has been implicated as having both oncogenic and tumor suppression properties in cancer. LncRNAH19 transcripts also serve as a precursor for miR-675....
SourceID wanfang
proquest
pubmed
crossref
springer
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 363
SubjectTerms Blotting, Western
Carcinoma, Hepatocellular - genetics
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - pathology
cdc25 Phosphatases - metabolism
Cell Line
Cell Line, Tumor
Cell Movement - genetics
Down-Regulation
Gene Expression Regulation, Neoplastic
Gene Knockdown Techniques
Glycogen Synthase Kinase 3 - metabolism
Glycogen Synthase Kinase 3 beta
Hep G2 Cells
HepG2细胞
Humans
Liver Neoplasms - genetics
Liver Neoplasms - metabolism
Liver Neoplasms - pathology
Medicine
Medicine & Public Health
MicroRNAs - genetics
Neoplasm Invasiveness
Proto-Oncogene Proteins c-akt - metabolism
Reverse Transcriptase Polymerase Chain Reaction
RNA Interference
RNA, Long Noncoding - genetics
Signal Transduction
Western印迹
侵袭
信号通路
定量RT-PCR
聚合酶链反应
肝癌细胞
迁移
Title Downregulation of LncRNAH19 and MiR-675 Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells through AKT/GSK-3β/Cdc25A Signaling Pathway
URI http://lib.cqvip.com/qk/85740A/201403/49956835.html
https://link.springer.com/article/10.1007/s11596-014-1284-2
https://www.ncbi.nlm.nih.gov/pubmed/24939300
https://www.proquest.com/docview/1537592601
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e201403011
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwELZQKyEuiH9SoDJST6CoSew4yTEqbVeU7aGwUjlZju1sF6hTmhTad-EpeBCeiZnE2S0CVeKaxE7kmczMZ8_MR8iWEpE1qeJhnOko5NzGYSUMoFbNGc9twgqN-5DTQzGZ8bfH6bGv427HbPfxSLK31KtiN_C8iH6xz17OQ7C76ylAd1TrWVKO5hfi54HJVmSYVsnYeJT5rymwocJJ4-Zf4XV_Oqa_os1rJ6V9fY-rlZtfc0V798hdH0PSchD6fXLLugfk9tSfkj8kP94AtD4fSOZh2WlT03dOHx2Wk7igyhk6XRyFEMLTsz4Xz7b0dDEfNKG_vXDfVOsH9hx-9AScVtfgJj9mrVKNBESuOVUUL7XUk_1QCBi3998fhOzXz-0do5O0pJgforDknSL38Xd19YjM9nY_7ExCz8IQanD2XVirrBBGFTquTBwZQDTg4y0XrFZCJIoDurbCsLQuojpXYHhtbvsug8irXhvNHpM11zj7lMA3iUpEjLGaA-xRosgMy02qNYRhxvAsIBtLccizoduG5Fh7C3FiQKJRPlL7_uVIo_FFrjovo3gliFeieGUSkFfLIeN0Nzz8chS6hF8M108521y0EpxClhbYey0gTwZtWE4H6JUVLIoC8npUD-mtQHvTu7a8Bq0e7j5dfTaXl5W0CaJeNLwb_zXpM3IHRw55bM_JWnd-YV9AxNRVm2S93P94sLvZ_ym_Afk9DFI
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3bbtNAEF2hVAJeKNficlukPoHcOtn1On6MSttALg8llcrTar27TkPpuq0daPkWvoIP4ZuY8SUpF1Xqa2KP48x4Zo7ncgjZUCKwJlTcb0c68Dm3bT8RBlCr5ox3bYfFGt9Djsaif8A_HIaH9Rx33nS7NyXJ0lMvh90g8iL6xT17Xe6D313hAMHDFlnp7X0a7DQOGDLoistWRNhYyVhTzPyfEFypcJS56Rlc8M_Q9E--eaVWWk74uFS56ZVgtLtKJs1tVD0ox5vzItnU3__a8HjD-7xP7tXJKe1V1vSA3LLuIbk9qsvvj8iPd4DZzyv2etAnzVI6dHp_3Ou3Y6qcoaPZvg_YgJ6WTX42pyezaWVi5dcz91Xl9YklOSA9gmhYZFg9wHZYqpHZyGUniuJHOa1ZhChkolt7Hwc--_Vza9voTtij2HiicJaeIqnyN3X5mBzs7ky2-35N7-BryCIKP1VRLIyKdTsx7cAAVILkwXLBUiVER3GA7VYYFqZxkHYVeHTbteX6QiRsT41mT0jLZc4-JfCbRCICxljKAU8pEUeGdU2oNeR3xvDII-sLLcvTao2H5DjUCwmoR4JG7VLXi9GRn-OLXK50RpVIUIlElciOR94sTmnEXXPw68aWJDy7-P8pZ7N5LiHaRGGMS908slYZ2UIcwGIWsyDwyNvGTGTtXvLrrrVRG-by4OLz5bG5uEik7SCcRo--fiOhr8id_mQ0lMP348EzchelVM1yz0mrOJ_bF5CWFcnL-jH8DQ4cKnQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwELZQkSouiH9SChipJ1C0Sew4yXHVsiy0u0KFlXqzHNvZbqHOtkmhfReeggfhmZjJz24RqBLXxB5HmfH82DPzEbKjRGBNrLgfJjrwObehnwsDUavmjKc2YpnGc8jJVIxn_MNRfNThnFZ9tnt_JdnWNGCXJlcPlqYYrAvfwApjJIw991Lugw6-Ddo4xJyuWTTsVTH40i2qrUgwxZKx_lrzXySwucJx6eZnsPSfRuovz_ParWlT6-MK5ebXzNLoHrnb-ZN02ArAfXLLugdkc9LdmD8kP_YgzD5vAeeBBbQs6IHTh9PhOMyocoZOFoc-uPN02eTl2YqeLuatVDSvF-6bqrqJDZ4fPQYDVpd44I8ZrFQjGJErTxXFRxXtgH8oOI-Dd5_2ffbr52DX6CgeUswVUVj-ThEH-bu6ekRmo7efd8d-h8jgazD8tV-oJBNGZTrMTRgYiG7A3lsuWKGEiBSHSNsKw-IiC4pUgRK2qW06DiLGemE0e0w2XOnsUwLfJHIRMMYKDiGQElliWGpircElM4YnHtlasUMu284bkmMdLviMHgl6_kjd9TJHSI2vct2FGdkrgb0S2Ssjj7xeTenJ3TD4Vc90CdsN_59ytryoJBiIJM6wD5tHnrTSsCIHkSzLWBB45E0vHrLTCNVNa-10ErQeXJ9cfTGXl7m0EUbAqIS3_ovoS7L5cW8kD95P95-RO0ikTW_bJhv1-YV9Do5Unb9oNstvvkcR7Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Downregulation+of+LncRNAH19+and+MiR-675+promotes+migration+and+invasion+of+human+hepatocellular+carcinoma+cells+through+AKT%2FGSK-3%CE%B2%2FCdc25A+signaling+pathway&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Lv%2C+Jun&rft.au=Ma%2C+Ling&rft.au=Chen%2C+Xi-lin&rft.au=Huang%2C+Xiao-hui&rft.date=2014-06-01&rft.issn=1672-0733&rft.eissn=1993-1352&rft.volume=34&rft.issue=3&rft.spage=363&rft.epage=369&rft_id=info:doi/10.1007%2Fs11596-014-1284-2&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11596_014_1284_2
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg